Compliance & Legal

When large hospitals and health systems buy or affiliate with smaller facilities, the deals can benefit both parties.

With an annual rate of 11,000 fatalities from falls in U.S. hospitals, falls are a persistent concern for healthcare facilities.

With the Office for Civil Rights gearing up to begin auditing providers, the best thing to do is to be prepared.

California's lingering backlog of Medi-Cal applications has left hundreds of thousands of people unable to access the healthcare they are entitled to receive, according to a lawsuit filed Wednesday.

The 340B program is critical for hospitals and other providers that serve some of our country's poorest and most vulnerable patients. When providers monitor compliance and track 340B drugs properly, the program can fulfill its intended purpose.

A Pennsylvania provider is suing a health insurance company for passing on its 2 percent reimbursement cut required by sequestration.

Although a May 2014 U.S. District Court ruling vacated HRSA's 340B orphan drug regulation, the agency has issued an interpretive rule affirming its policy on the orphan drug exemption. The pharma industry is up in arms, but what does it all mean?

After more than a year of dispute over continuing a contract, insurer and new health system owner Highmark and the University of Pittsburgh Medical Center have reached a comprehensive transition agreement.

An Illinois home health case heard recently by the Supreme Court could reach far beyond that sector, dramatically changing the way labor unions operate across the country.

The American Hospital Association is asking federal Medicare leaders to stem the practice of using sample hospital audit data to extrapolate overpayments eligible for recovery. The lack of clarity regarding standards for short patient stays has clouded the issue.